PBS waitlist grows again

By Megan Brodie 2 years ago | In Products, Regulatory
  • 2 years ago

3 August 2022 Almost two years after the TGA approved Otsuka’s orphan newcomer INQOVI (decitabine/cedazuridine)…

This is subscriber-only content. Please login to continue reading.